– USA, PA – AmerisourceBergen Corporation (NYSE: ABC) today announced that Ornella Barra, Executive Vice President of Walgreens Boots Alliance, Inc. (Walgreens Boots Alliance) (NASDAQ: WBA) and President and Chief Executive of Global Wholesale and International Retail has been elected to its Board of Directors, effective immediately. Ms. Barra has been appointed by the Board to fill the vacancy created by Gregory D. Wasson’s resignation from the Company’s Board on January 9, 2015 following Mr. Wasson’s retirement from Walgreens Boots Alliance. Ms. Barra has not been appointed to serve on any committees of the Board.
Walgreens Boots Alliance is entitled to designate a director (including any successor director to fill an unexpired term) to the AmerisourceBergen Board of Directors as part of its strategic long-term relationship with the Company.
“We are very pleased to have Ornella join the AmerisourceBergen Board of Directors,” said Richard C. Gozon, Chairman of the Board of AmerisourceBergen. “Her extensive experience in wholesale pharmaceutical distribution and international health and pharmaceutical retail industries and strategic insight will be an asset to our Board, particularly as we continue to grow our global operations. Ms. Barra also provides a valuable perspective on our strategic relationship and collaboration with Walgreens Boots Alliance.” Commenting on Mr. Wasson’s resignation from AmerisourceBergen’s Board, Mr. Gozon said “Mr. Wasson has garnered tremendous respect from the Board during his tenure and the Board wishes to thank him for his contributions to the continuing success of AmerisourceBergen.”
“I am thrilled to have Ornella join our Board of Directors,” added Steven H. Collis, President and Chief Executive Officer of AmerisourceBergen. “She has a deep understanding of the needs of our customers, including pharmacists, and the demands of running a global enterprise. I am confident that Ornella will contribute in countless ways as we continue to advance AmerisourceBergen’s strategic goals and objectives.”
Ms. Barra is currently serving as Executive Vice President of Walgreens Boots Alliance and President and Chief Executive of Global Wholesale and International Retail. Prior to this, she was Chief Executive Wholesale and Brands of Alliance Boots. Ms. Barra had previously been Chief Executive of the Pharmaceutical Wholesale Division of Alliance Boots (from January 2009 to September 2013), and before that, Wholesale & Commercial Affairs Director. In her role, she was responsible for the Pharmaceutical Wholesale Division as well as the overall development of International Health & Beauty and Brands of Alliance Boots. Ms. Barra is Chairman of the International Federation of Pharmaceutical Wholesalers (IFPW) and is also a member of the Board of Directors of Assicurazioni Generali. Ms. Barra began her career as a pharmacist in Italy and is Honorary Professor at the University of Nottingham School of Pharmacy.
AmerisourceBergen is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel. With nearly $120 billion in annual revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs approximately 14,000 people. AmerisourceBergen is ranked #28 on the Fortune 500 list.
- Disclaimer - News, data and statement included in this release are intended exclusively for general information purposes. Talent4Boards accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the adequacy or accuracy of the information. No data or statement in this release should be considered for decisions about securities referred. Product and brand names used in this release maybe trademarks or registered trademarks of their respective owners.
Comments are closed.